To reduce the average length of stay of patients who are admitted for DA-EPOCH-R chemotherapy regimen
Y M Lee
BMJ Quality Improvement Reports 2015;4: doi:10.1136/bmjquality.u208379.w3434
Monday, 20 April 2015
To reduce the average length of stay of patients who are admitted for DA-EPOCH-R chemotherapy regimen
"A quality improvement project was initiated to review and revise the workflow and processes involved for the entire episode of treatment. A post-implementation review of the interventions showed cost savings, a reduction of average length of stay from seven days to six days (with a total of 28 days saved over six months), and improved patient and staff experience."
To reduce the average length of stay of patients who are admitted for DA-EPOCH-R chemotherapy regimen
Y M Lee
BMJ Quality Improvement Reports 2015;4: doi:10.1136/bmjquality.u208379.w3434
Read more here.
To reduce the average length of stay of patients who are admitted for DA-EPOCH-R chemotherapy regimen
Y M Lee
BMJ Quality Improvement Reports 2015;4: doi:10.1136/bmjquality.u208379.w3434
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment